CDEK
← All drugs Report issue

oteracil

Small moleculeexperimental

Clinical trial activity

470 trials · 234 clinical orgs · 0 marketing orgs

Phase 1
68
Phase 2
398
Phase 3
84
Phase 4
11

Earliest trial started May 1, 2000 (NCT00209638)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2000

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

O=C(O)c1nc(=O)[nH]c(=O)[nH]1
Mol. weight
157.08 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 5-azaorotic acid
  • 5-azaorotic acid
  • 5-azaorotic acid
  • allantoxanic acid
  • allantoxanic acid
  • oteracil
  • oteracil
  • oteracil
  • oteracil
  • oteracil
  • oteracil
  • oteracil
  • oteracil potassium
  • oxonate
  • oxonate
  • oxonic acid
  • oxonic acid
  • oxonic acid
  • oxonic acid potassium salt
  • potassium oxonate
  • potassium oxonate
  • potassium oxonate
  • potassium oxonate
  • potassium oxonate
  • s-1
  • s-1
  • tegafur / gimeracil / oteracil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07243938Phase 2Jan 15, 2026Huazhong University of Science and Technology
NCT07304258Phase 2Dec 12, 2025Hebei University
NCT07182565Phase 1/Phase 2 (Phase 2)Nov 18, 2025Sichuan University
NCT07263386Phase 2Oct 23, 2025Nanjing Medical University
NCT07018063Phase 2Oct 1, 2025Peking University
NCT07007182Phase 2Oct 1, 2025Shandong University
NCT07161453Phase 4Sep 30, 2025Dalian Medical University
NCT07151209Phase 2Sep 30, 2025Nanjing Medical University
NCT07072351Phase 1/Phase 2 (Phase 2)Sep 15, 2025Sichuan University
NCT07194005Phase 2Sep 4, 2025Fudan University
NCT07132528Phase 4Aug 31, 2025Dalian Medical University
NCT07149181Phase 4Aug 31, 2025Dalian Medical University
NCT07033143Phase 2Jul 31, 2025Tianjin Medical University
NCT07023315Phase 3Jul 31, 2025Akeso Pharmaceuticals, Inc.
NCT06973330Phase 2Jul 31, 2025Anhui Medical University
NCT07068516Phase 3Jul 20, 2025Chinese Academy of Medical Sciences, Dalian Medical University, University of Electronic Science and Technology of China
NCT07070479Phase 2Jun 24, 2025Sun Yat-Sen University
NCT07026149Phase 2Jun 8, 2025Jiao Tong University
NCT07025889Phase 1/Phase 2 (Phase 2)Jun 2, 2025Jiao Tong University
NCT06949033Phase 3May 15, 2025LanZhou University
Showing 20 of 470 trials
Page 1 / 24

Organizations

Research & Development (234)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chinese Academy of Medical SciencesAcademic/Hospital524442009
OtsukaFor profit372332000
Fudan UniversityAcademic/Hospital312842010
People's Liberation Army of ChinaGovernment201932009
Sun Yat-Sen UniversityAcademic/Hospital202022008
Zhejiang UniversityAcademic/Hospital181742010
Jiao Tong UniversityAcademic/Hospital161322016
Nanjing Medical UniversityAcademic/Hospital151332016
Peking UniversityAcademic/Hospital151132005
Tianjin Medical UniversityAcademic/Hospital141232009
Fujian Medical UniversityAcademic/Hospital121042016
National Cancer Center, KoreaGovernment12732004
University of UlsanAcademic/Hospital12922004
Yonsei UniversityAcademic/Hospital121032006
Hebei UniversityAcademic/Hospital11932009
Chang Gung UniversityAcademic/Hospital9132008
Hallym UniversityAcademic/Hospital9722005
Hengrui Therapeutics, Inc.For profit9022015
National Cheng Kung UniversityAcademic/Hospital9122009
National Taiwan UniversityAcademic/Hospital9422012
234 organizations
Page 1 / 12